Trial intelligence / Profile preview

RFA vs Phenol Neurolysis for Chronic Coccydynia

NCT07021365Not yet recruiting

Sponsor
Marmara University
Start
Jul 2025
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of phenol in coccydynia (2 arms), sponsored by Marmara University. Primary endpoint: Numeric Rating Scale at 6 months. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

phenol
03

Conditions

coccydynia

Beyond the preview

Go deeper on NCT07021365.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07021365.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call